Profile picture

Doctor Clotilde Roy

Jolimont Lobbes Hospital, La Louviere (Belgium)
Follow
Logo ESC

Contributor content

Fibroblast growth factor 23 and extracellular volume as markers of myocardial fibrosis and poor outcome in heart failure with preserved ejection fraction
Presentation
Fibroblast growth factor 23 and extracellular volume as markers of myocardial fibrosis and poor outcome in heart failure with preserved ejection fraction
Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction
Presentation
Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction
Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction
Presentation
Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction
Prognostic relevance of right ventricle global longitudinal strain in heart failure with preserved ejection fraction.
Presentation
Prognostic relevance of right ventricle global longitudinal strain in heart failure with preserved ejection fraction.
Age and gender interaction with t1, t2, t2* and extracellular volume reference values in healthy volunteers at 3 tesla cardiac magnetic resonance.
Presentation
Age and gender interaction with t1, t2, t2* and extracellular volume reference values in healthy volunteers at 3 tesla cardiac magnetic resonance.
Prognostic significance of diffuse myocardial fibrosis evaluated by cMR in patients with heart failure with preserved ejection fraction.
Presentation
Prognostic significance of diffuse myocardial fibrosis evaluated by cMR in patients with heart failure with preserved ejection fraction.

ESC 365 is supported by